Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr;155(4):1115-1123.
doi: 10.1016/j.jaci.2024.12.1092. Epub 2025 Jan 10.

Update on mast cell biology

Affiliations
Review

Update on mast cell biology

Hadas Tamar Pahima et al. J Allergy Clin Immunol. 2025 Apr.

Abstract

Mast cells (MCs) are heterogeneous tissue-resident effector cells that are thought to play central roles in allergic inflammatory disease, yet the degree of heterogeneity and nature of these roles has remained elusive. In recent years, advances in tissue culture systems, preclinical mouse models, and the continued spread of single-cell RNA sequencing have greatly advanced our understanding of MC phenotypes in health and disease. These approaches have identified novel interactions of MC subsets with immune cells, neurons, and tissue structural cells, changing our understanding of how MCs both drive and help resolve tissue inflammation, reshape tissue microenvironments, and influence host behavior. This review addresses key studies from 2022 to 2024 that have advanced our understanding of MC biology in mice and humans.

Keywords: Mast cell progenitors; mast cell heterogeneity; single-cell RNA sequencing; type 2 inflammation.

PubMed Disclaimer

Conflict of interest statement

Disclosure statement Supported by the National Institutes of Health (grants U19 AI095219, R01 HL174622, and R21 AI186023) and by generous contributions from the Vinik family. D. F. Dwyer reports compensation for consulting services with Celldex Therapeutics, Blueprint Medicines, and Monte Rosa Therapeutics and research funding from Blueprint Medicines. The remaining author declares that she has no relevant conflicts of interest.